Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency
Sabine Kroiss, Manuela AlbisettiDivision of Hematology, University Children’s Hospital, Zurich, SwitzerlandAbstract: Protein C is one of the major inhibitors of the coagulation system that downregulate thrombin generation. Severe congenital protein C deficiency leads to a hypercoagulab...
Guardado en:
Autores principales: | Sabine Kroiss, Manuela Albisetti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08281d4ded334a03a102e25ce501da85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
por: Paul N Knoebl
Publicado: (2008) -
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
por: Mirza Waseem Javed, et al.
Publicado: (2020) -
Fibrinogen and C-Reactive-Protein Variation in Mild and Severe Preeclampsia
por: SH Yazdani, et al.
Publicado: (2010) -
Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction
por: M Hashemian,, et al.
Publicado: (2011) -
C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia
por: Chang CH, et al.
Publicado: (2019)